|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/48 | |||
| A61K 31/513 |
| (11) | Patento numeris | 1819323 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05852790.4 |
| Europos patento paraiškos padavimo data | 2005-12-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-08-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/043675 |
| Data | 2005-12-02 |
| (87) | Numeris | WO 2006/060681 |
| Data | 2006-06-08 |
| (30) | Numeris | Data | Šalis |
| 632859 P | 2004-12-03 | US |
| (72) |
CRUANES, Maria, T., US
XU, Wei, US
ARTINO, Laura, M., US
ZHU, Honggang, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT |
| PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT |